The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.
Aspergillus fumigatus Forms Biofilms with Reduced Antifungal Drug Susceptibility on Bronchial Epithelial Cells
Open accessAbstract
Aspergillus fumigatus is a leading cause of death in immunocompromised patients and a frequent colonizer of the respiratory tracts of asthma and cystic fibrosis (CF) patients. Biofilms enable bacteria and yeasts to persist in infections and can contribute to antimicrobial resistance. We investigated the ability of A. fumigatus to form biofilms on polystyrene (PS) and human bronchial epithelial (HBE) and CF bronchial epithelial (CFBE) cells. We developed a novel in vitro coculture model of A. fumigatus biofilm formation on HBE and CFBE cells. Biofilm formation was documented by dry weight, scanning electron microscopy (SEM), and confocal scanning laser microscopy (CSLM). The in vitro antifungal activities of seven antifungal drugs were tested by comparing planktonic and sessile A. fumigatus strains. A. fumigatus formed an extracellular matrix on PS and HBE and CFBE cells as evidenced by increased dry weight, SEM, and CSLM. These biofilms exhibited decreased antifungal drug susceptibility and were adherent to the epithelial cells, with fungi remaining viable throughout 3 days. These observations might have implications for treatment of A. fumigatus colonization in chronic lung diseases and for its potential impact on airway inflammation, damage, and infection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, a number of these biofilm formers (Table 3) have been tested for drug susceptibility in vitro, and cells in biofilms have been found to be more resistant to drugs compared with cells grown in suspension culture.”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [176]
In the citing paper
“Aspergillus fumigatus is a common invasive colonizer of the respiratory tract in individuals with cystic fibrosis or other conditions that compromise the immune system (176).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [176]
In the citing paper
“These include (in addition to Candida) members from Acremonium, Aspergillus, Cladosporium, Fusarium, and Pneumocystis (9, 20, 35, 42, 79, 160, 176).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [176]
Citations
Cites
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1773-1780.2002 · Cited by 775
Wald, A., Leisenring, W., van Burik, J., & Bowden, R. A. (1997) · The Journal of Infectious Diseases · doi:10.1086/516480 · Cited by 742
Inhibition of Candida albicans Biofilm Formation by Farnesol, a Quorum-Sensing Molecule
Ramage, G., Saville, S. P., Wickes, B. L., & Lopez-Ribot, J. L. (2002) · Applied and Environmental Microbiology · doi:10.1128/aem.68.11.5459-5463.2002 · Cited by 702
Ramage, G., Saville, S. P., Thomas, D. P., & López-Ribot, J. L. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.4.633-638.2005 · Cited by 678
The pathobiology of Aspergillus fumigatus
Latgé, J. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02104-7 · Cited by 547
Invasive Mold Infections in Allogeneic Bone Marrow Transplant Recipients
Baddley, J. W., Stroud, T. P., Salzman, D. E., & Pappas, P. G. (2001) · Clinical Infectious Diseases · doi:10.1086/319985 · Cited by 364
An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus
Beauvais, A., Schmidt, C., Guadagnini, S., Roux, P., Perret, E., Henry, C., Paris, S., Mallet, A., Prévost, M.-C., & Latgé, J. P. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00895.x · Cited by 262
Mowat, E., Butcher, J., Lang, S., Williams, C., & Ramage, G. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47247-0 · Cited by 259
Haemophilus influenzae Forms Biofilms on Airway Epithelia
Starner, T. D., Zhang, N., Kim, G., Apicella, M. A., & McCray, P. B. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1459oc · Cited by 207
Research works printed but not linked: 2
- Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; M38-A 2002 vol. 22
- Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother. 2006
Cited by
Sorted by citations
Candida albicans Biofilms and Human Disease
Nobile, C. J., & Johnson, A. D. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104330 · Cited by 1,057
Ramage, G., Rajendran, R., Sherry, L., & Williams, C. (2012) · International Journal of Microbiology · doi:10.1155/2012/528521 · Cited by 583
Regulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576
Antifungal Resistance and New Strategies to Control Fungal Infections
Vandeputte, P., Ferrari, S., & Coste, A. T. (2011) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 531
Our Current Understanding of Fungal Biofilms
Ramage, G., Mowat, E., Jones, B., Williams, C., & Lopez-Ribot, J. (2009) · Critical Reviews in Microbiology · doi:10.3109/10408410903241436 · Cited by 483
Delhaes, L., Monchy, S., Fréalle, E., Hubans, C., Salleron, J., Leroy, S., Prevotat, A., Wallet, F., Wallaert, B., Dei-Cas, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036313 · Cited by 347
Paulussen, C., Hallsworth, J. E., Álvarez‐Pérez, S., Nierman, W. C., Hamill, P. G., Blain, D., Rediers, H., & Lievens, B. (2016) · Microbial Biotechnology · doi:10.1111/1751-7915.12367 · Cited by 368
Candida Species Biofilms’ Antifungal Resistance
Silva, S. M., Rodrigues, C. F., Araújo, D., Rodrigues, M. E., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010008 · Cited by 317
Hsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms
Robbins, N., Uppuluri, P., Nett, J., Rajendran, R., Ramage, G., Lopez-Ribot, J. L., Andes, D., & Cowen, L. E. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002257 · Cited by 291
Fungal Biofilms and Polymicrobial Diseases
Costa-Orlandi, C. B., Sardi, J. D. C. O., Pitangui, N. D. S., de Oliveira, H. C., Scorzoni, L., Galeane, M. C., Medina‐Alarcón, K. P., Melo, W., Marcelino, M., Braz, J. D., et al. (2017) · Journal of Fungi · doi:10.3390/jof3020022 · Cited by 247
Characterization of Bacterial and Fungal Biofilms in Chronic Rhinosinusitis
Foreman, A., Psaltis, A. J., Tan, L. W., & Wormald, P. (2009) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2009.23.3413 · Cited by 195
Rajendran, R., Williams, C., Lappin, D. F., Millington, O., Martins, M., & Ramage, G. (2013) · Eukaryotic Cell · doi:10.1128/ec.00287-12 · Cited by 173
Watanabe, N.-A., Miyazaki, M., Horii, T., Sagane, K., Tsukahara, K., & Hata, K. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00731-11 · Cited by 169
Fungal biofilm architecture produces hypoxic microenvironments that drive antifungal resistance
Kowalski, C. H., Morelli, K. A., Schultz, D., Nadell, C. D., & Cramer, R. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003700117 · Cited by 151
Balducci, E., Papi, F., Capialbi, D. E., & Bino, L. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044030 · Cited by 166
Aspergillus Cell Wall and Biofilm
Beauvais, A., Fontaine, T., Aimanianda, V., & Latgé, J. (2014) · Mycopathologia · doi:10.1007/s11046-014-9766-0 · Cited by 149
The Interface between Fungal Biofilms and Innate Immunity
Kernien, J. F., Snarr, B. D., Sheppard, D. C., & Nett, J. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01968 · Cited by 158
Aspergillus biofilms: clinical and industrial significance
Ramage, G., Rajendran, R., Gutierrez-Correa, M., Jones, B., & Williams, C. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2011.02381.x · Cited by 136
Aspergillus fumigatusMedA governs adherence, host cell interactions and virulence
Gravelat, F. N., Ejzykowicz, D. E., Chiang, L. Y., Chabot, J. C., Urb, M., MacDonald, K., Al-Bader, N., Filler, S. G., & Sheppard, D. C. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01408.x · Cited by 138
In vitrocharacterization ofTrichophyton rubrumandT. mentagrophytesbiofilms
Costa-Orlandi, C. B., Sardi, J. D. C. O., Santos, C. T., Fusco‐Almeida, A. M., & Mendes‐Giannini, M. J. S. (2014) · Biofouling · doi:10.1080/08927014.2014.919282 · Cited by 137
Biofilm formation byAspergillus fumigatus
Kaur, S., & Singh, S. (2013) · Medical Mycology · doi:10.3109/13693786.2013.819592 · Cited by 128
Sass, G., Nazik, H., Penner, J., Shah, H., Ansari, S. R., Clemons, K. V., Groleau, M.-C., Dietl, A.-M., Visca, P., Haas, H., et al. (2018) · Journal of Bacteriology · doi:10.1128/jb.00345-17 · Cited by 128
Aspergillus fumigatus biofilms in the clinical setting
Müller, F.-M. C., Seidler, M., & Beauvais, A. (2011) · Medical Mycology · doi:10.3109/13693786.2010.502190 · Cited by 123
Self-citationGibbons, J. G., Beauvais, A., Beau, R., McGary, K. L., Latgé, J., & Rokas, A. (2011) · Eukaryotic Cell · doi:10.1128/ec.05102-11 · Cited by 115
Fungal Biofilms: Relevance in the Setting of Human Disease
Martinez, L. R., & Fries, B. C. (2010) · Current Fungal Infection Reports · doi:10.1007/s12281-010-0035-5 · Cited by 121
Fungi in the cystic fibrosis lung: Bystanders or pathogens?
Chotirmall, S. H., & McElvaney, N. G. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.03.001 · Cited by 118
Microbial Biofilms in Pulmonary and Critical Care Diseases
Boisvert, A.-A., Cheng, M. P., Sheppard, D. C., & Nguyen, D. M. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201603-194fr · Cited by 114
Morelli, K. A., Kerkaert, J. D., & Cramer, R. A. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009794 · Cited by 101
Therapeutic Challenges of Non- Aspergillus Invasive Mold Infections in Immunosuppressed Patients
Lamoth, F., & Kontoyiannis, D. P. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01244-19 · Cited by 99
Microbial glycoside hydrolases as antibiofilm agents with cross-kingdom activity
Snarr, B. D., Baker, P., Bamford, N. C., Sato, Y., Liu, H., Lehoux, M., Gravelat, F. N., Ostapska, H., Baistrocchi, S. R., Cerone, R. P., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702798114 · Cited by 95
Bruns, S., Seidler, M. J., Albrecht, D., Salvenmoser, S., Remme, N., Hertweck, C., Brakhage, A. A., Kniemeyer, O., & Müller, F. C. (2010) · PROTEOMICS · doi:10.1002/pmic.201000129 · Cited by 95
Self-citationAspergillus Biofilm In Vitro and In Vivo
Beauvais, A., & Latgé, J. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0017-2015 · Cited by 102
Ferreira, J. A. G., Penner, J. C., Moss, R. B., Haagensen, J. A. J., Clemons, K. V., Spormann, A. M., Nazik, H., Cohen, K., Banaei, N., Carolino, E., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134692 · Cited by 92
Hidden killers: persistence of opportunistic fungal pathogens in the human host
d’Enfert, C. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.05.008 · Cited by 90
Cellulase production by Aspergillus niger in biofilm, solid-state, and submerged fermentations
Gamarra, N., Villena, G. K., & Gutiérrez-Correa, M. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2540-4 · Cited by 91
González-Ramírez, A. I., Ramírez‐Granillo, A., Medina‐Canales, M. G., Rodríguez-Tovar, A. V., & Martínez-Rivera, M. Á. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0859-4 · Cited by 91
Recent Advances on Filamentous Fungal Biofilms for Industrial Uses
Gutiérrez-Correa, M., Ludeña, Y., Ramage, G., & Villena, G. K. (2012) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-012-9555-5 · Cited by 81
Candida Species: New Insights into Biofilm Formation
Cuéllar-Cruz, M., López-Romero, E., Villagómez-Castro, J. C., & Ruiz-Baca, E. (2012) · Future Microbiology · doi:10.2217/fmb.12.48 · Cited by 80
Manavathu, E. K., Vager, D. L., & Vazquez, J. A. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-53 · Cited by 80
Ramírez‐Granillo, A., Medina‐Canales, M. G., Espindola, M. E. S., Martínez-Rivera, M. Á., Lucio, V. M. B., & Rodríguez-Tovar, A. V. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0363-2 · Cited by 84
Resistance mechanism and proteins in Aspergillus species against antifungal agents
Shishodia, S. K., Tiwari, S., & Shankar, J. (2019) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2019.1574927 · Cited by 82
Liu, S., Mauff, F. L., Sheppard, D. C., & Zhang, S. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00347-3 · Cited by 75
Shopova, I. A., Bruns, S., Thywißen, A., Kniemeyer, O., Brakhage, A. A., & Hillmann, F. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00141 · Cited by 75
Fiori, B., Posteraro, B., Torelli, R., Tumbarello, M., Perlin, D. S., Fadda, G., & Sanguinetti, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01569-10 · Cited by 73
de Mello, T. P., Aor, A. C., Gonçalves, D. D. S., Seabra, S. H., Branquinha, M. H., & dos Santos, A. L. S. (2016) · Biofouling · doi:10.1080/08927014.2016.1192610 · Cited by 71
Intravenous antibiotics reduce the presence ofAspergillusin adult cystic fibrosis sputum
Baxter, C. G., Rautemaa‐Richardson, R., Jones, A. M., Webb, A. K., Bull, M. J., Mahenthiralingam, E., & Denning, D. W. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202412 · Cited by 67
Beauvais, A., Loussert-Fonta, C., Prévost, M. C., Verstrepen, K. J., & Latgé, J. P. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00482.x · Cited by 70
Fungal Biofilms: Update on Resistance
Borghi, E., Borgo, F., & Morace, G. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_7 · Cited by 69
Delsuc, C., Cottereau, A., Fréalle, É., Bienvenu, A., Dessein, R., Jarraud, S., Dumitrescu, O., Maréchal, M. L., Wallet, F., Friggeri, A., et al. (2015) · Critical Care · doi:10.1186/s13054-015-1140-1 · Cited by 66
Mauff, F. L., Bamford, N. C., Alnabelseya, N., Zhang, Y., Baker, P., Robinson, H. H., Codée, J. D. C., Howell, P. L., & Sheppard, D. C. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008511 · Cited by 65
Anti-Aspergillus Activities of the Respiratory Epithelium in Health and Disease
Bertuzzi, M., Hayes, G., Icheoku, U., Van Rhijn, N., Denning, D., Osherov, N., & Bignell, E. (2018) · Journal of Fungi · doi:10.3390/jof4010008 · Cited by 64
El-Ganiny, A. M., Sheoran, I. S., Sanders, D. A. R., & Kaminskyj, S. G. W. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2010.03.002 · Cited by 63
Biofilm formation byFusarium oxysporumf. sp.cucumerinumand susceptibility to environmental stress
Li, P., Xiaoming, P., Huifang, S., Jingxin, Z., Ning, H., & Bi-run, L. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12310 · Cited by 61
Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes
Song, J., & Stevens, D. A. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2015.1068271 · Cited by 62
Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs
Nett, J. E., & Andes, D. R. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0008-2014 · Cited by 68
Sav, H., Rafati, H., Öz, Y., Cılo, B. D., Ener, B., Mohammadi, F., İlkit, M., van Diepeningen, A., & Seyedmousavi, S. (2018) · Journal of Fungi · doi:10.3390/jof4010016 · Cited by 60
Correa-Royero, J., Tangarife, V. G., Durán, C., Stashenko, E. E., & Mesa-Arango, A. C. (2010) · Revista Brasileira de Farmacognosia · doi:10.1590/s0102-695x2010005000021 · Cited by 56
The Clinical Importance of Fungal Biofilms
Ramage, G., & Williams, C. (2013) · Advances in applied microbiology · doi:10.1016/b978-0-12-407673-0.00002-3 · Cited by 58
Pathogenesis of Fungal Infections in Cystic Fibrosis
Williams, C., Ranjendran, R., & Ramage, G. (2016) · Current Fungal Infection Reports · doi:10.1007/s12281-016-0268-z · Cited by 56
The clinical spectrum of aspergillosis in chronic obstructive pulmonary disease
Otu, A., Kosmidis, C., Mathioudakis, A. G., Ibe, C., & Denning, D. W. (2023) · Infection · doi:10.1007/s15010-022-01960-2 · Cited by 60
Biofilm Formation by Pseudallescheria/Scedosporium Species: A Comparative Study
Rollin‐Pinheiro, R., de Meirelles, J. V., Vila, T. V. M., Fonseca, B. B., Alves, V., Frasés, S., Rozental, S., & Barreto‐Bergter, E. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01568 · Cited by 51
Keratitis-Associated Fungi Form Biofilms with Reduced Antifungal Drug Susceptibility
Zhang, X., Sun, X., Wang, Z., Zhang, Y., & Hou, W. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.12-10810 · Cited by 49
Bugli, F., Posteraro, B., Papi, M., Torelli, R., Maiorana, A., Sterbini, F. P., Posteraro, P., Sanguinetti, M., & Spirito, M. D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01875-12 · Cited by 48
Aspergillus Biofilm In Vitro and In Vivo
Beauvais, A., & Latgé, J. (2015) · ASM Press eBooks · doi:10.1128/9781555817466.ch8 · Cited by 47
Effects of Iron Chelators on the Formation and Development of Aspergillus fumigatus Biofilm
Nazik, H., Penner, J. C., Ferreira, J. A. G., Haagensen, J. A. J., Cohen, K., Spormann, A. M., Martinez, M., Chen, V., Hsu, J. L., Clemons, K. V., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01684-15 · Cited by 46
Smith, D. F. Q., & Casadevall, A. (2021) · Pathogens and Disease · doi:10.1093/femspd/ftab013 · Cited by 48
Next-generation antifungal drugs: Mechanisms, efficacy, and clinical prospects
Lu, X., Zhou, J., Ming, Y., Wang, Y., He, R., Li, Y., Feng, L., Zeng, B., Du, Y., & Wang, C. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.06.013 · Cited by 50
Biofilm formation in clinically relevant filamentous fungi: a therapeutic challenge
Roudbary, M., Vahedi‐Shahandashti, R., dos Santos, A. L. S., Mohammadi, S. R., Aslani, P., Lass‐Flörl, C., & Rodrigues, C. F. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1950121 · Cited by 46
Melloul, É., Luiggi, S., Anaïs, L., Arné, P., Costa, J., Fihman, V., Briard, B., Dannaoui, É., Guillot, J., Decousser, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166325 · Cited by 44
Lagree, K., & Mitchell, A. P. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0024-2016 · Cited by 41
Aspergillus Fumigatus Biofilm on Primary Human Sinonasal Epithelial Culture
Singhal, D., Baker, L. M., Wormald, P., & Tan, L. (2011) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2011.25.3622 · Cited by 41
Amorim, A. A., Vaz, L. G., & Araújo, R. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.007 · Cited by 41
Perdoni, F., Signorelli, P., Cirasola, D., Caretti, A., Galimberti, V., Biggiogera, M., Gasco, P., Musicanti, C., Morace, G., & Borghi, E. (2015) · BMC Microbiology · doi:10.1186/s12866-015-0588-0 · Cited by 41
Mohammadi, F., Ghasemi, Z., Familsatarian, B., Salehi, E., Sharifynia, S., Barikani, A., Mirzadeh, M., & Hosseini, M. A. (2020) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0214-2019 · Cited by 42
Management of invasive aspergillosis in patients with COPD: rational use of voriconazole
Ader, F. (2009) · International Journal of COPD · doi:10.2147/copd.s4229 · Cited by 40
UnusualAspergillusspecies in patients with cystic fibrosis
Symoens, F., Haase, G., Pihet, M., Carrère, J., Béguin, H., Degand, N., Mély, L., & Bouchara, J. (2010) · Medical Mycology · doi:10.3109/13693786.2010.501345 · Cited by 38
Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis
Müller, F. C., & Seidler, M. J. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.72 · Cited by 38
Self-citationFungal Biofilm Composition and Opportunities in Drug Discovery
Reichhardt, C., Stevens, D. A., & Cegelski, L. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0049 · Cited by 38
Ader, F. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-010-0132-1 · Cited by 35
de Mello, T. P., Oliveira, S. S. C., Frasés, S., Branquinha, M. H., & dos Santos, A. L. S. (2018) · Biofouling · doi:10.1080/08927014.2018.1503652 · Cited by 35
Manfiolli, A. O., dos Reis, T. F., de Assis, L. J., de Castro, P. A., Silva, L. P., Hori, J. I., Walker, L. A., Munro, C. A., Rajendran, R., Ramage, G., et al. (2018) · The Cell Surface · doi:10.1016/j.tcsw.2018.03.002 · Cited by 36
Sen, S., Borah, S. N., Bora, A., & Deka, S. (2020) · Biotechnology Reports · doi:10.1016/j.btre.2020.e00516 · Cited by 40
Actividad antimicótica y citotóxica de aceites esenciales de plantas de la familia Asteraceae
Zapata, B., Durán, C., Stashenko, E. E., Betancur-Galvis, L. A., & Mesa-Arango, A. C. (2010) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2010.01.005 · Cited by 34
Brilhante, R. S. N., Correia, E. E. M., Guedes, G. M. D. M., de Oliveira, J. S., Castelo‐Branco, D. D. S. C. M., Cordeiro, R. D. A., Pinheiro, A. D. Q., Chaves, L. J. Q., Neto, W. D. A. P., Sidrim, J. J. C., et al. (2018) · Mycoses · doi:10.1111/myc.12763 · Cited by 32
Kirchhoff, L., Dittmer, S., Weisner, A.-K., Buer, J., Rath, P., & Steinmann, J. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa157 · Cited by 31
Reen, F. J., Phelan, J. P., Woods, D. F., Shanahan, R., Cano, R., Clarke, S., McGlacken, G. P., & O’Gara, F. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02074 · Cited by 28
Escande, W., Fayad, G., Modine, T., Verbrugge, E., Koussa, M., Senneville, É., & Leroy, O. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2011.01.102 · Cited by 28
Garcia, L. M., Costa-Orlandi, C. B., Bila, N. M., Vaso, C. O., Gonçalves, L. N. C., Fusco‐Almeida, A. M., & Mendes‐Giannini, M. J. S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01980 · Cited by 28
Kirchhoff, L., Dittmer, S., Furnica, D.-T., Buer, J., Steinmann, E., Rath, P., & Steinmann, J. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac062 · Cited by 28
Biofilm disruption with rotating microrods enhances antimicrobial efficacy
Mair, L. O., Nacev, A. N., Hilaman, R., Stepanov, P. Y., Chowdhury, S., Jafari, S., Hausfeld, J. N., Karlsson, A. J., Shirtliff, M. E., Shapiro, B., et al. (2016) · Journal of Magnetism and Magnetic Materials · doi:10.1016/j.jmmm.2016.10.100 · Cited by 27
Fauvel, M., Farrugia, C., Tsapis, N., Gueutin, C., Cabaret, O., Bories, C., Bretagne, S., & BARRATT, G. M. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.012 · Cited by 27
Barião, P. H. G., Tonani, L., Brancini, G. T. P., Nascimento, É., Braga, G. Ú. L., Wainwright, M. S., & Kress, M. R. V. Z. (2022) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-022-00258-4 · Cited by 26
Aspergillus Biofilms in Human Disease
Williams, C., Rajendran, R., & Ramage, G. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_4 · Cited by 26
Toukabri, N., Corpologno, S., Bougnoux, M., Euch, D. E., Sadfi‐Zouaoui, N., & Simonetti, G. (2017) · Mycoses · doi:10.1111/myc.12706 · Cited by 25
Fungal Biofilms in Human Disease
Williams, C., & Ramage, G. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-09782-4_2 · Cited by 25
In Vitro Interactions of Antifungal Agents and Tacrolimus against Aspergillus Biofilms
Gao, L., & Sun, Y. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01510-15 · Cited by 24
Kashyap, V. H., Mishra, A., Bordoloi, S., Varma, A. K., & Joshi, N. C. (2023) · Mycoses · doi:10.1111/myc.13619 · Cited by 22
Kerkaert, J. D., Mauff, F. L., Wucher, B. R., Beattie, S. R., Vesely, E. M., Sheppard, D. C., Nadell, C. D., & Cramer, R. A. (2022) · mBio · doi:10.1128/mbio.02933-21 · Cited by 21
Immunopathologic Role of Fungi in Chronic Rhinosinusitis
Shin, S., Ye, M., Lee, D., & Geum, S.-Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032366 · Cited by 26
Anand, R., Clemons, K. V., & Stevens, D. A. (2017) · Archives of Microbiology · doi:10.1007/s00203-017-1362-5 · Cited by 23
Metadata
- Authors
- Seidler, M. J., Salvenmoser, S., & Müller, F.-M. C.
- Affiliations
- Heidelberg University (DE)
- Pediatric Pulmonology, Cystic Fibrosis Centre and Infectious Diseases, Department of Pediatrics III, University of Heidelberg, Im Neuenheimer Feld 430, D-69120 Heidelberg, Germany
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2008-11
- Volume
- 52
- Issue
- 11
- Pages
- 4130-4136
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2573142
- OpenAlex
- W2098670630
- Cited by
- 229
- References
- 22
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 8 · 2023: 11 · 2022: 16 · 2021: 16 · 2020: 14 · 2019: 6 · 2018: 13 · 2017: 18 · 2016: 14 · 2015: 16 · 2014: 12 · 2013: 13 · 2012: 8
- FWCI
- 9.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Aspergillus fumigatus, biofilm formation, antifungal susceptibility, bronchial epithelial cells, cystic fibrosis, extracellular matrix, fungal adhesion, polystyrene, antifungal resistance, chronic lung disease, airway colonization, immunocompromised patients
- MeSH terms
- Antifungal Agents, Aspergillosis, Aspergillus fumigatus, Bronchi, Cells, Cultured, Cystic Fibrosis, Epithelial Cells, Humans, Microbial Sensitivity Tests, Microscopy, Electron, Scanning, Respiratory Tract Infections, Biofilms, Microscopy, Confocal, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review